Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring

Clinical Pharmacokinetics

Volumn 39, Issue 3, 2000, Pages 233-242

  Timmer, Cees J ^a   Mulders, Titia M T ^a  

^a NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; DESOGESTREL; ETHINYLESTRADIOL; ETONOGESTREL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VAGINA RING;

EID: 0033795487     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200039030-00005     Document Type: Article

References (3)

1. Mishell DR, Talas M, Parlow AF, et al. Contraception by means of a Silastic vaginal ring impregnated with medroxyprogesterone acetate. Am J Obstet Gynecol 1970; 107: 100-7
2. Odlind V. New delivery systems for hormonal contraception. Acta Obstet Gynecol Scand Suppl 1986; 134: 15-20
3. de Leede LGJ, Govers CPM, de Nijs H. A multicompartment vaginal ring system for independently adjustable release of contraceptive steroids. Contraception 1986; 34: 589-602